DR was graded according to early Treatment Diabetic Retinopathy (ETDRS ... with mild non proliferative DR (NPDR), 34 patients (17.1%) with moderate NPDR, 22 patients (11.1%) with severe NPDR ...

Full details of the evidence and the committee's discussion are in evidence review A: prognostic factors for progression of non-proliferative diabetic retinopathy.

Full details of the evidence and the committee's discussion are in evidence review H: clinical features or factors that suggest treatment should be switched or stopped for people diagnosed with ...

Diabetic vitreous hemorrhage is linked to neuropathologic changes in specific brain regions, as identified by voxel-based morphometry. Reduced morphometry values in certain brain areas correlate with ...

in noninferior to anti-VEGF treatment for proliferative diabetic retinopathy (PDR). Additionally, not all DME requires treatment. “If you look at subclinical, non-center involved DME and follow ...

Loss to follow-up higher among men who are Black or Hispanic, or those who must travel farther to care facilities.

First patient dosed in the pediatric cohort of the Phase 1/2 trial of OPGx-LCA5; initial data on the cohort anticipated by Q3 2025New 12-month ...

First patient dosed in the pediatric cohort of the Phase 1/2 trial of OPGx-LCA5; initial data on the cohort anticipated by Q3 2025New 12-month data on the first three adult OPGx-LCA5 patients to be pr ...

Kodiak Sciences Inc. (NASDAQ:KOD – Get Free Report) was the target of a significant growth in short interest during the month of January. As of January 31st, there was short interest totalling ...

Abnormal expression of serum Ephrin-A1 and CTRP9 in diabetic retinopathy patients. In addition, serum Ephrin-A1 in proliferative diabetic retinopathy patients was higher than that in non-proliferative ...

Diabetic retinopathy (DR) is a leading cause of visual impairment ... STDR was defined as the presence of preproliferative DR (R2), proliferative DR (R3) and/or maculopathy (M1). Photographs that were ...